Tanuj Banker, MD
Retina Specialist · Sarasota, FLNPI 1447542410
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (47.9%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Astellas Pharma US Inc at 50.8% of the total.
Across 62 payments — averaging $262.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$8K
- LKC Technologies, Inc.$5K
- Notal Vision, Inc.$1K
- Genentech USA, Inc.$533
- Apellis Pharmaceuticals, Inc.$279
- Tarsus Pharmaceuticals, Inc.$244
- plus $1K from 15 others
What the payments were for
- Consulting fees$7,80148%
- Speaking & faculty fees$5,87136%
- Food & beverage$2,51715%
- Education$891%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 11 | $8,265 |
| LKC Technologies, Inc. | 1 | $4,500 |
| Notal Vision, Inc. | 7 | $1,411 |
| Genentech USA, Inc. | 13 | $533 |
| Apellis Pharmaceuticals, Inc. | 5 | $279 |
| Tarsus Pharmaceuticals, Inc. | 2 | $244 |
| Regeneron Healthcare Solutions, Inc. | 7 | $207 |
| Cardinal Health 110 LLC | 1 | $150 |
| Rxsight Inc | 1 | $130 |
| Glaukos Corporation | 1 | $121 |
| Novartis | 2 | $119 |
| Lensar, Inc. | 1 | $83 |
| AbbVie(2 entities) | 2 | $49 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $46 |
| Harrow Eye, LLC | 1 | $40 |
| Masimo Corporation | 1 | $20 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $19 |
| Alimera Sciences, Inc. | 1 | $19 |
| Halozyme Inc | 1 | $17 |
| Coherus Oncology, Inc. | 1 | $15 |
| Ocular Therapeutix, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Izervay$8,048
- XDEMVY$244
- Syfovre$228
- Lucentis$213
- LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD)$130
How this compares
$16,278 in reported general payments places this provider in the 80th percentile of 118 retina specialist providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 275 | $10,846 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 21 | $4,356 |
| Difluprednate | 26 | $2,545 |
| Brimonidine Tartrate | 45 | $2,452 |
| Ketorolac Tromethamine | 91 | $1,805 |
| Latanoprost | 114 | $1,423 |
| MoxifloxacinMoxifloxacin Hcl | 51 | $1,149 |
| ValacyclovirValacyclovir Hcl | 13 | $1,126 |
| Dorzolamide-TimololDorzolamide/Timolol/Pf | 14 | $987 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 37 | $569 |
| Timolol Maleate | 76 | $503 |
| ErythromycinErythromycin Base | 24 | $196 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 13 | $103 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Sarasota
- Keye WongSarasota$23K
- John NiffeneggerSarasota$16K
- Elizabeth RichterSarasota$15K
- Sunil GuptaPensacola$1.8M
- Joseph NezgodaWest Palm Beach$600K
- Eduardo UchiyamaFt Lauderdale$356K
- Thomas AlbiniMiami$281K
- Audina BerrocalMiami$210K
- Philip RosenfeldMiami$206K
- John MyersPensacola$152K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.